The vascular impact of dapagliflozin, liraglutide, and atorvastatin alone or in combinations in type 2 diabetic rat model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The vascular impact of dapagliflozin, liraglutide, and atorvastatin alone or in combinations in type 2 diabetic rat model

Published:2022-02-15 Issue:4 Volume:36 Page:731-741
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

El Medany Azza Mohammed Hafez¹,Hammadi Sami Hussein Mahmoud¹,Khalifa Hoda Mahmoud²,Ghazala Rasha Abdelmawla³,Zakaria Mohammed Hend Samir¹^ORCID

Affiliation:

1. Clinical Pharmacology Department, Faculty of Medicine Alexandria University Alexandria Egypt

2. Histology Department, Faculty of Medicine Alexandria University Alexandria Egypt

3. Medical Biochemistry Department, Faculty of Medicine Alexandria University Alexandria Egypt

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12765

Reference39 articles.

1. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

2. Microvascular Complications of Type 2 Diabetes Mellitus

3. Vascular Complications of Diabetes

4. An update on pharmacotherapies in diabetic dyslipidemia

5. Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy;Pharmacology & Therapeutics;2023-09

2. Sodium‐glucose cotransporter 2 inhibitors: A comprehensive review from cells to bedside;Fundamental & Clinical Pharmacology;2022-12-27

3. Dapagliflozin Presented Nonalcoholic Fatty Liver Through Metabolite Extraction and AMPK/NLRP3 Signaling Pathway;Hormone and Metabolic Research;2022-12-09

4. The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features;Biomolecules;2022-09-02

5. Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?;Frontiers in Endocrinology;2022-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3